Dr. Meyyappan will lead Fidelion’s global commercial strategy and partnerships, including the development of clinical, laboratory, and pharmaceutical collaborations to support the adoption of advanced ...

For the first time, Colossal BioSciences unveiled its Dallas labs where it is spending millions of dollars researching how to revive extinct animals and save endangered ones.

The report arrives as the global peptide synthesis market reaches approximately $1.9 billion in 2026, on track to reach $2.59 billion by 2031 at a 6.39% compound annual growth rate. North America ...

By Sahil Pandey and Bageshri Banerjee March 9 (Reuters) - Life sciences firm Agilent Technologies said on Monday that it will acquire privately held clinical pathology firm Biocare Medical in an ...

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.